Clinical Trial Update: A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers [Phase 2]

View source ↗

Summary

Phase IIa trial evaluating the safety and immunogenicity of a DNA HIV-1 vaccine followed by an MVA HIV-1 vaccine in HIV-uninfected volunteers, which has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DNA HIV-1 vaccine
• MVA HIV-1 vaccine

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV Infections | Phase 2 | Status: COMPLETED